Classical swine fever (CSF) (hog cholera) virus infection is still of world-wide concern, either because of the direct effects of the disease on swine breeding in areas where the virus is epizootic or enzootic, or as a threat in areas where the virus has been eradicated. The authors provide an overview of the characteristics of the disease. Special emphasis is placed on the chronic form of disease, particularly in the late stages of eradication programmes. In the early 1980s, the European Union (EU) was composed of countries which were officially free of the disease (absence of infection and no vaccination) and countries in which vaccination was either permitted or was compulsory. To ensure free trade between the Member States, an eradication plan was agreed upon and implemented. Initially, the plan consisted of a combination of vaccination with the Chinese strain of the virus and slaughter and removal of infected herds. Consequently, when the number of infected herds was low, vaccination was abandoned and the control of CSF was conducted exclusively by eradication (removal and slaughter). The United Kingdom, Austria, Denmark, Ireland, Luxembourg, Finland and Sweden ceased vaccination before 1980. In the other countries, vaccination was useful in controlling the last epidemics and was finally ceased as follows: France in 1983, the Netherlands in 1986, Belgium, Spain and Greece in 1988, Germany in 1989 and Italy in 1990. From 1990 onwards, no vaccination against CSF has been performed in the EU. New techniques for the diagnosis of CSF (for example, the enzyme-linked immunosorbent assay based on the detection of the p125 antigen of the virus) have been shown to be of value in the early detection of infected animals. In enzootic areas, the use of vaccines based on the Chinese strain has been successful. Vaccines with at least 100 PD50 of virus per dose are able to significantly limit the replication of virulent virus in the tonsils. Consequently, shedding of virus after infection can be reduced considerably. In heavily infected areas, vaccination plays a crucial role. The European experience shows that eradication may be achieved when vaccination with highly effective vaccines is combined with effective identification of swine, movement control, early diagnosis and the rapid elimination of infected herds.
Introduction
Classical swine fever (CSF) (hog choiera) remains of major world-wide concern: in disease-free areas, introduction of the disease is a constant threat and in contaminated areas, eradication is the ultimate target. In both cases, the basic characteristics of the CSF virus should be considered whether attempting to maintain or achieve officiai freedom from CSF.
The disease is induced by a small enveloped RNA (ribonucleic acid) virus named classical swine fever virus (CSFV), belonging to the Flaviviridae family, genus Pestivirus (36) .
The virus leads to a systemic disease and provokes a variety of symptoms in pigs. The most common signs in acute cases are high température (> 40°C) and haemorrhages on the ears and abdomen. Thèse symptoms are accompanied by respiratory disease, enteric disease and central nervous disturbances.
Symptoms of the chronic form are much less typical, for example, wasting and growth delay, particularly in cases where the other symptoms considered as typical are absent.
Différences in strain virulence (9, 23, 34) and the immunological status of the pig affected seem to be the major factors influencing this varying clinical picture.
The présence of imrrtunotolerant animais persistently infected with strains of low virulence may complicate early diagnosis of the infection. Thèse animais do not express typical signs and fail to produce antibodies (13) , making serological diagnosis problematic. This situation is similar to immunotolerance exhibited by ruminants infected with the pestiviruses bovine virus diarrhoea virus (BVDV) of cattle and border disease virus (BDV) of sheep (8) . Van Oirschot and Terpstra described the case of a carrier sow affected by a field outbreak (50) . The animal gave birth to a litter of 11 piglets.
All piglets had CSFV in their pre-colostral plasma. Six piglets were followed until death. At day two after birth, the piglets had high virus titres in the plasma although ail had ingested colostrum with a high antibody titre against CSFV. Finally, all animais developed clinical signs, very late after birth, commonly known as late onset'. Signs such as increasing anorexia and depression, conjunctivitis, dermatitis and locomotion disturbances in varying degrees were noticed and death ultimately occurred at 332 days after birth. None of the piglets developed antibodies against CSFV. Vannier et al. experimentally reproduced immunotolerant animals from sows infected at 43 days of gestation (48) . A similar syndrome was reproduced by Paton and Done in pigs congenitally infected with ruminant-type pestiviruses (38) . Chronic infection with CSFV may occur after infection with moderately virulent virus types or with strains which provoke chronic cases of the disease (9, 34) . The virus may transiently disappear from the sérum before reappearance of clinical disease in a less clearly pronounced form. Such persistently infected animais play an important role in the epidemiology of the disease since the animais are not clearly affected clinically but harbour and may excrète the virus for several months.
Wild boars can also act as a source of CSF infection (4, 11) .
Vaccines are an efficient tool to limit the circulation of the virus in a swine population, on the condition that the vaccines comply with high safety and efficacy requirements and are properly applied.
In the early 1980s, some countries in Europe (United Kingdom, Ireland and Denmark) were already completely free of CSF: no vaccination or infection occurred in those countries. However, other countries in Europe were infected Gaining officiai status of freedom from classical swine fever in the European Union 1. Free of classical swine fever: no classical swine fever has been diagnosed during the last 12 months.
2. Officially free of classical swine fever: no classical swine fever has been diagnosed during the last 12 months, no swine vaccinated against classical swine fever are present and vaccination against classical swine fever has not been authorised for at least 12 months.
3. Region: a country can be divided into well-defined régions which may not all have an identical disease status. This system does not automatically block a whole country for trade if only some of thèse régions are affected by CSF (17) .
According to this legislation, all EU Member States were expected to become officially free of CSF five years after having presented an eradication plan.
In areas infected with CSF, vaccination was initially intensified in order to cover the entire swine population. The gênerai vaccination programme was accompanied by well-defined measures to be taken in case of suspicion or confirmation of the disease, financial measures for compensation, and procedures for identification and tracing of infection. In the case of vaccination, only vaccines that were produced from the Chinese strain and that had at least 100 PD50 (protective dose 50%) were allowed (7, 30) . Table I .
Cessation of vaccination against classical swine fever in the European Union
Twelve months after the last country in the EU ceased vaccination, the EU regarded itself as officially free from CSF.
After that date, the legislation according to the Directive EEC/80/217 (14) was applied and in case of problems, special measures were taken by decision of the Commission. Those measures were based on tracing, identification, laboratory analysis and eradication of herds and contact herds. Contacts by swine, transport vehicles and humans are the main channels for transmission of CSF. Identification and registration of animais are both essential in order to detect contacts among farms. Tracing forwards and backwards is necessary and probably the most difficult aspect of every eradication attempt.
Germany was also confronted with CSF outbreaks in 1993
and 1994, simultaneously with Belgium (39). Genome analysis (32, 44) of the isolates provided interesting data regarding the epidemiology. However, genomic différences cannot be related to différent protective patterns among virulent strains and vaccine strains.
In 1997, CSF reappeared in the Netherlands, Germany, Belgium, Spain and Italy (1, 2, 35) . The genomic profile of the isolates and tracing of infected and contact herds through the identification system revealed that all these epidemics were probably linked. Authorities in Belgium were successful in rapidly eradicating the seven infected herds and fifty-five contact herds as a preventive measure. As a consequence, the country regained status of officiai freedom from CSF within 40 days (35) . Eradication was equally successful in Italy.
In the EU, the control of CSF remains based on eradication without vaccination. The issue of the use of deleted vaccines, offering the possibility to differentiate between infected and vaccinated animais has been raised. Data currently available for deleted vaccines do not answer the questions of how to detect immunotolerant animais and pigs chronically infected with CSF viruses or whether deleted vaccines offer the same rapid protection in an emergency situation as presently available vaccines (7, 53) . Furthermore, it is uncertain whether deleted vaccines will offer the same degree of efficacy (> 100 PD50 per dose of vaccine). The Scientific Veterinary Committee of the EU identified several areas for further investigation, as follows (21): Currently, vaccination has been completely discontinued in countries of the EU. In contrast, the situation in countries in Asia can be compared with that of the EU before 1980. Experience and knowledge from both the EU and Asia should be shared for a better understanding of control measures in the future. Vaccination is still common practice in several countries in Central and Eastem Europe.
Vaccination and eradication
The situation in Member States of the EU ten to fifteen years ago, demonstrates that controlled vaccination and tracing of movement of pigs are vital steps towards control of the disease. Vaccination was undertaken under following conditions:
-high standards of safety and efficacy were maintained (7, 30) -vaccines contained at least 100 PD50 per dose of vaccine -vaccines were administered under officiai control.
In an infected environment, vaccines are the basic tools for control and eradication. Vaccines can drastically reduce the circulation of virulent virus and prohibit or significantly minimise the économie losses due to CSF, on the condition that the vaccines used meet the highest standards of safety and efficacy and that administration is correctly performed.
The vaccines currently used are produced either using rabbits (lapinized vaccines) or cell cultures. In both cases the most widely used strain is the Chinese strain. The efficacy and safety of this strain have been proven world-wide (29, 30, 40, 45, 49) . However, the system of production of the vaccine may significantly influence safety and efficacy. Vaccines produced using rabbits pose the problem of the standardisation of the vaccine viral content. The frequent use of these vaccines in sows has demonstrated that piglets from vaccinated sows may react anaphylactically when vaccinated themselves with lapinised vaccine (6) . This problem has been solved by adapting the Chinese strain to cell culture and by elimination of all protein of rabbit origin from the final product. The latter vaccine has been adapted to an ovine continuous dell line. This vaccine has been scrutinised for safety in more than 15,000 swine, including pregnant sows, piglets and fattening swine. Safety of the vaccine has been confirmed by the use of millions of doses (internai Merial data).
The vaccine produced on ovine cell line meets the efficacy requirement (minimum 100 PD50 per dose) and is an interesting tool for controlling the circulation of a virulent virus (7). This vaccine, with an antigenic content of 480 PD50, was able to limit strongly, if not completely, the réplication of virulent challenge virus in the tonsils, when pigs were infected oronasally at one week after vaccination performed in piglets at six weeks old. Long-term immunity using the same vaccine has been successfully demonstrated (41) . This type of vaccine has been extremely useful in the eradication of CSF in the EU where vaccination was accompanied by elimination of infected animais and herds. However, in régions or countries where a policy of slaughter of infected animais does not exist, the situation is more complicated, as discussed below.
Vaccination in the présence of maternai antibodies
In an infected environment, sows may have high antibody titres due to infection with virulent virus. Their offspring may have higher maternai antibodies than offspring of vaccinated non-infected sows. In thèse herds, revaccination of piglets is recommended at the age of nine weeks, or even later in some cases, because of interference of maternai antibodies with vaccination at a younger âge. As stated earlier, persistently infected animais pose an important risk and are difficult to detect. In a vaccinated environment, thèse animais should be found and eliminated.
Persistently infected animais: response to vaccination
Immunotolerant animais are unlikely to respond to vaccination (33) . Animais that have been chronically infected with CSF do not always demonstrate a clear antibody response following a CSF infection. It is not known how thèse animais react to vaccination, however, chronically infected pigs shed CSF virus.
The usefulness of precolostral vaccination
Although technically proven, the practicability of precolostral vaccination is an important obstacle (28, 29) .
Diagnosis
The clinical signs that are typical of CSF consist of petechiae on the skin, reddening of ear tops, anorexia and fever, accompanied by central nervous disturbances and diarrhoea.
The incubation period of CSFV is approximately six days.
Early signs, such as anorexia and fever, appear from the 
Conclusions
The method of control of CSF will primarily depend on the disease situation and legislation in the country concerned. In areas where the disease frequency and/or pig density is low, Nuevas técnicas de diagnóstico de la peste porcina clásica, como el ensayo inmunoenzimático para la detección del antígeno p125 del virus, han demostrado ser de gran utilidad para la detección precoz de animales infectados. En zonas donde la enfermedad es endémica, el uso de vacunas con la cepa china parece sumamente eficaz. Las vacunas con un mínimo de 100 PD50 de virus por dosis son capaces de contener de forma significativa la replicación del virus virulento en las amígdalas, lo que reduce considerablemente la excreción de virus y su difusión en el entorno. En zonas con elevada tasa de infección, las vacunaciones desempeñan un papel crucial. La experiencia europea demuestra que es posible erradicar la enfermedad combinando el uso de vacunas de gran eficacia con una identificación eficiente de los animales que permita controlar sus desplazamientos, establecer un sistema de diagnóstico precoz y eliminar con rapidez los rebaños infectados.
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